Cargando…
c-MycER(TAM )transgene silencing in a genetically modified human neural stem cell line implanted into MCAo rodent brain
BACKGROUND: The human neural stem cell line CTX0E03 was developed for the cell based treatment of chronic stroke disability. Derived from fetal cortical brain tissue, CTX0E03 is a clonal cell line that contains a single copy of the c-mycER(TAM )transgene delivered by retroviral infection. Under the...
Autores principales: | Stevanato, Lara, Corteling, Randolph L, Stroemer, Paul, Hope, Andrew, Heward, Julie, Miljan, Erik A, Sinden, John D |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2725042/ https://www.ncbi.nlm.nih.gov/pubmed/19622162 http://dx.doi.org/10.1186/1471-2202-10-86 |
Ejemplares similares
-
Generation of c-MycER(TAM)-transduced human late-adherent olfactory mucosa cells for potential regenerative applications
por: Santiago-Toledo, Gerardo, et al.
Publicado: (2019) -
Human Neural Stem Cell Therapy for Chronic Ischemic Stroke: Charting Progress from Laboratory to Patients
por: Sinden, John D., et al.
Publicado: (2017) -
Implantation of the clinical‐grade human neural stem cell line, CTX0E03, rescues the behavioral and pathological deficits in the quinolinic acid‐lesioned rodent model of Huntington's disease
por: Yoon, Yongwoo, et al.
Publicado: (2020) -
The effects of microRNAs on human neural stem cell differentiation in two- and three-dimensional cultures
por: Stevanato, Lara, et al.
Publicado: (2014) -
Differentiation of a Human Neural Stem Cell Line on Three Dimensional Cultures, Analysis of MicroRNA and Putative Target Genes
por: Stevanato, Lara, et al.
Publicado: (2015)